MYO — Myomo Inc
AMEX · Healthcare · Medical Devices
$1.40
-$0.03 (-2.10%)
Myomo Inc (MYO) is a medical devices company listed on AMEX. It is led by Paul R. Gudonis, based in 45 Blue Sky Dr., Burlington, MA, United States, 01803, with about 194 employees. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
Latest reported MYO revenue for 2025-09-30 was $10.1M. Net income was -$11.8M. Revenue was up 4.5% from 2025-06-30 to 2025-09-30. MYO currently screens at market cap $57.6M.
Use this MYO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MYO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MYO SEC filings page. Lician reads the product cache first so this HTML stays unique to Myomo Inc even when a live quote feed is slow.
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
MYO Key Statistics
Market Cap
$57.57M
Volume
566,763
Previous Close
$1.39
Day Range
$1.39 – $1.50
P/B Ratio
6.57
EPS
-$0.16
Revenue
$32.55M
Net Income
-$6.18M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+69.2%
Profit Margin
-19.0%
Employees
194
MYO Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $32.55M | $19.24M | $15.56M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.18M | -$8.15M | -$10.72M |
| EPS (Diluted) | -$0.16 | -$0.28 | -$1.52 |
Total Assets
$42.24M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$24.37M
Operating Cash Flow
-$3.29M
Free Cash Flow
$0.00
Myomo Inc Company Information
- President, CEO & Chairman
- Paul R. Gudonis
- Headquarters
- 45 Blue Sky Dr., Burlington, MA, United States, 01803
- Website
- myomo.com
- Phone
- 617 996 9058
- IPO / Founded
- 2017-06-12
- Sector
- Healthcare
- Industry
- Medical Devices